Blueberries Medical Corp.
BBM
CNSX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 47.58% | 41.29% | 59.59% | -7.69% | -7.39% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 47.58% | 41.29% | 59.59% | -7.69% | -7.39% |
| Cost of Revenue | 36.01% | 44.10% | 46.63% | -25.33% | -19.81% |
| Gross Profit | 68.39% | 36.99% | 91.19% | 20.66% | 29.83% |
| SG&A Expenses | 19.44% | 11.81% | -26.85% | -6.01% | -9.34% |
| Depreciation & Amortization | -45.98% | -38.00% | -30.94% | 5.46% | 26.05% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 13.53% | 10.45% | -18.20% | -7.48% | -7.66% |
| Operating Income | -5.63% | -3.43% | 34.52% | 7.41% | 7.71% |
| Income Before Tax | -14.90% | -10.05% | 31.01% | 9.77% | 18.53% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -14.90% | -10.05% | 31.01% | 9.77% | 18.53% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -14.90% | -10.05% | 31.01% | 9.77% | 18.53% |
| EBIT | -5.63% | -3.43% | 34.52% | 7.41% | 7.71% |
| EBITDA | -14.53% | -9.09% | 35.06% | 1.17% | 5.30% |
| EPS Basic | 25.71% | 36.96% | 62.50% | 37.21% | 42.62% |
| Normalized Basic EPS | 22.22% | 36.00% | 64.52% | 48.00% | 57.14% |
| EPS Diluted | 25.71% | 36.96% | 62.50% | 37.21% | 42.62% |
| Normalized Diluted EPS | 22.22% | 36.00% | 64.52% | 48.00% | 57.14% |
| Average Basic Shares Outstanding | 37.13% | 51.48% | 81.95% | 69.16% | 57.88% |
| Average Diluted Shares Outstanding | 37.13% | 51.48% | 81.95% | 69.16% | 57.88% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |